Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

CV Sciences (CVSI) Equity Average (2016 - 2025)

CV Sciences' Equity Average history spans 14 years, with the latest figure at $1.5 million for Q4 2025.

  • On a quarterly basis, Equity Average fell 24.56% to $1.5 million in Q4 2025 year-over-year; TTM through Dec 2025 was $1.5 million, a 24.56% decrease, with the full-year FY2025 number at $1.6 million, down 30.54% from a year prior.
  • Equity Average hit $1.5 million in Q4 2025 for CV Sciences, down from $1.7 million in the prior quarter.
  • Over the last five years, Equity Average for CVSI hit a ceiling of $11.6 million in Q1 2021 and a floor of $294000.0 in Q4 2022.
  • Historically, Equity Average has averaged $3.9 million across 5 years, with a median of $2.5 million in 2024.
  • Biggest five-year swings in Equity Average: crashed 96.0% in 2022 and later soared 985.37% in 2023.
  • Tracing CVSI's Equity Average over 5 years: stood at $7.3 million in 2021, then crashed by 96.0% to $294000.0 in 2022, then soared by 985.37% to $3.2 million in 2023, then crashed by 37.54% to $2.0 million in 2024, then dropped by 24.56% to $1.5 million in 2025.
  • Business Quant data shows Equity Average for CVSI at $1.5 million in Q4 2025, $1.7 million in Q3 2025, and $1.8 million in Q2 2025.